ARTICLE | Company News
Deltagen admet news
January 13, 2003 8:00 AM UTC
DGEN said it is discontinuing all drug discovery programs to focus on its drug discovery tools and products business, including its in vivo mammalian transgenic technologies. In addition, DGEN will re...